ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 140 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,544,276 | -13.5% | 147,923 | +1.3% | 0.01% | -18.8% |
| Q4 2022 | $2,941,024 | -35.2% | 146,029 | -30.3% | 0.02% | -33.3% |
| Q3 2022 | $4,536,000 | -42.2% | 209,434 | -25.1% | 0.02% | -41.5% |
| Q2 2022 | $7,854,000 | +29.0% | 279,510 | +111.8% | 0.04% | +17.1% |
| Q1 2022 | $6,088,000 | -14.7% | 131,940 | +55.4% | 0.04% | -10.3% |
| Q4 2021 | $7,138,000 | +126.3% | 84,912 | +79.4% | 0.04% | +95.0% |
| Q3 2021 | $3,154,000 | +118.7% | 47,322 | +74.5% | 0.02% | +100.0% |
| Q2 2021 | $1,442,000 | – | 27,114 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 | $177,556,000 | 4.47% |
| Avidity Partners Management LP | 2,493,800 | $166,187,000 | 3.68% |
| Matrix Capital Management Company, LP | 4,349,279 | $289,836,000 | 3.30% |
| Integral Health Asset Management, LLC | 90,000 | $5,998,000 | 1.72% |
| Affinity Asset Advisors, LLC | 77,500 | $5,165,000 | 1.30% |
| Ghost Tree Capital, LLC | 65,000 | $4,332,000 | 1.27% |
| Ikarian Capital, LLC | 200,000 | $13,328,000 | 0.94% |
| HighVista Strategies LLC | 20,596 | $1,373,000 | 0.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 23,855 | $1,590,000 | 0.90% |
| Woodline Partners LP | 507,847 | $33,843,000 | 0.55% |